Gordon Bernard MD
Critical Care Medicine, Clinical Informatics
Professor, Medicine, Vanderbilt University School of Medicine
Join to View Full Profile
21st Ave SNashville, TN 37232
Phone+1 615-343-0077
Dr. Bernard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gordon Bernard is a pulmonologist based in Nashville, TN, with subspecialties in Critical Care Medicine and Clinical Informatics. He completed his residency in Internal Medicine at the University of Kentucky College of Medicine and a fellowship in Pulmonary Disease and Critical Care Medicine at Vanderbilt University Medical Center. His expertise includes critical care medicine, pulmonary vascular disease, and general pulmonology. He has numerous publications in prominent medical journals, such as NEJM, JAMA Network Open and Chest, focusing on multicenter trials, sepsis, and COVID-19. Dr. Bernard has also been involved in clinical trials examining conditions like severe pneumonia, severe sepsis, and septic shock.
Education & Training
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1979 - 1981
University of Kentucky College of MedicineResidency, Internal Medicine, 1976 - 1979
Louisiana State University School of Medicine in New OrleansClass of 1976
Certifications & Licensure
TN State Medical License 1979 - 2027
LA State Medical License 1976 - 1979
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
ABIMCritical Care Medicine
Clinical Trials
- Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients Start of enrollment: 2002 Jun 01
- A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock Start of enrollment: 2010 Oct 01
- Ticagrelor in Severe Community Acquired Pneumonia Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- Untangling obese asthma: Design of proof-of-concept study of semaglutide in poorly controlled asthma.Alessandra Tomasello, Leonard B Bacharier, Patrice M Becker, Caeden Dempsey, Pingsheng Wu
The Journal of Allergy and Clinical Immunology. Global. 2026-03-01 - 2 citationsNormosol-R vs Lactated Ringers in the Critically Ill: A Randomized Trial.Edward T Qian, Ryan M Brown, Karen E Jackson, Li Wang, Joanna L Stollings
Chest. 2025-08-01 - 1 citationsEnhancing Multicenter Trials With the Trial Innovation Network's Initial Consultation Process.Paul A Harris, Consuelo H Wilkins, Karen Lane, Gordon R Bernard, Jonathan D Casey
JAMA Network Open. 2025-05-01
Press Mentions
Immune-Suppressing Drug Does Not Improve COVID-19 Recovery: StudyDecember 17th, 2024- Lowering Blood Pressure After Clot Removal May Not Be Safe; Should Be IndividualizedFebruary 10th, 2023
- VUMC Awarded $34 Million to Lead Nationwide Convalescent Plasma StudyAugust 21st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
